Showing results (111-120 of 245) with videos related to

Sort By:
Pageof 25
Oncogene|February 16, 2020
Therapeutic targeting of TP53-mutated acute myeloid leukemia by inhibiting HIF-1α with echinomycinYin Wang, Yan Liu, Christopher Bailey, et al.
Leukemia Research Reports|November 10, 2022
Therapy-related B-lymphoblastic leukemia after multiple myelomaMichael E Kallen, Rima Koka, Zeba N Singh, et al.
Plos One|December 14, 2012
MiR-27a functions as a tumor suppressor in acute leukemia by regulating 14-3-3θKara A Scheibner, Brianne Teaboldt, Mary Claire Hauer, et al.
International Journal of Molecular Epidemiology and Genetics|February 12, 2011
Genetic polymorphisms of ATP-binding cassette (ABC) proteins, overall survival and drug toxicity in patients with Acute Myeloid LeukemiaShalaka S Hampras, Lara Sucheston, Joli Weiss, et al.
Cancer Research Communications|January 29, 2024
Pim Kinase Inhibitors Increase Gilteritinib Cytotoxicity in FLT3-ITD Acute Myeloid Leukemia Through GSK-3β Activation and c-Myc and Mcl-1 Proteasomal DegradationJonelle K Lee, Aditi Chatterjee, Mario Scarpa, et al.
Annals of Hematology|July 18, 2020
Favorable outcomes of acute leukemias of ambiguous lineage treated with hyperCVAD: a multi-center retrospective studyVu H Duong, Kebede H Begna, Sarah Kashanian, et al.
International Journal of Cancer|April 27, 2011
Smoking adversely affects survival in acute myeloid leukemia patientsRamya Varadarajan, Andrea S Licht, Andrew J Hyland, et al.
Genes, Chromosomes & Cancer|August 5, 2005
Genomic profiling of myeloid sarcoma by array comparative genomic hybridizationGeorge Deeb, Maria R Baer, Daniel P Gaile, et al.
Molecular Cancer Therapeutics|February 11, 2021
PP2A-activating Drugs Enhance FLT3 Inhibitor Efficacy through AKT Inhibition-Dependent GSK-3β-Mediated c-Myc and Pim-1 Proteasomal DegradationMario Scarpa, Prerna Singh, Christopher M Bailey, et al.
International Journal of Molecular Epidemiology and Genetics|September 28, 2011
XPD DNA nucleotide excision repair gene polymorphisms associated with DNA repair deficiency predict better treatment outcomes in secondary acute myeloid leukemiaNataliya Kuptsova-Clarkson, Christine B Ambrosone, Joli Weiss, et al.
Pageof 25